Anew Medical, Current Valuation vs. EBITDA

WENADelisted Stock   0.73  0.05  6.41%   
Based on the key profitability measurements obtained from Anew Medical,'s financial statements, Anew Medical, may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Anew Medical,'s ability to earn profits and add value for shareholders.
For Anew Medical, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Anew Medical, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Anew Medical, utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Anew Medical,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Anew Medical, over time as well as its relative position and ranking within its peers.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Please note, there is a significant difference between Anew Medical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Anew Medical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anew Medical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Anew Medical, EBITDA vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Anew Medical,'s current stock value. Our valuation model uses many indicators to compare Anew Medical, value to that of its competitors to determine the firm's financial worth.
Anew Medical, is rated first in current valuation category among its peers. It is rated first in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Anew Medical,'s earnings, one of the primary drivers of an investment's value.

Anew Current Valuation vs. Competition

Anew Medical, is rated first in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Financials industry is at this time estimated at about 289.39 Billion. Anew Medical, adds roughly 18.58 Million in current valuation claiming only tiny portion of equities under Financials industry.

Anew EBITDA vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Anew Medical,

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
18.58 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Anew Medical,

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(1.3 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Anew EBITDA Comparison

Anew Medical, is currently under evaluation in ebitda category among its peers.

Anew Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Anew Medical,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Anew Medical, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Anew Medical,'s important profitability drivers and their relationship over time.

Use Anew Medical, in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anew Medical, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anew Medical, will appreciate offsetting losses from the drop in the long position's value.

Anew Medical, Pair Trading

Anew Medical, Pair Trading Analysis

The ability to find closely correlated positions to Anew Medical, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anew Medical, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anew Medical, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anew Medical, to buy it.
The correlation of Anew Medical, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anew Medical, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anew Medical, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anew Medical, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Anew Medical, position

In addition to having Anew Medical, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Dividend Beast Thematic Idea Now

Dividend Beast
Dividend Beast Theme
An experimental equal-weighted theme of equities with high dividend yield and solid fundamentals based on Macroaxis rating system. The Dividend Beast theme has 69 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Dividend Beast Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Anew Stock

If you are still planning to invest in Anew Medical, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anew Medical,'s history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine